Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults

JS Zifodya, I Schiller, N Dendukuri… - Cochrane Database …, 2019 - cochranelibrary.com
Background Xpert MTB/RIF (Xpert MTB/RIF) and Xpert MTB/RIF Ultra (Xpert Ultra), the
newest version, are the only World Health Organization (WHO)‐recommended rapid tests …

Xpert Ultra versus Xpert MTB/RIF for pulmonary tuberculosis and rifampicin resistance in adults with presumptive pulmonary tuberculosis

JS Zifodya, JS Kreniske, I Schiller… - Cochrane Database …, 2021 - cochranelibrary.com
Background Xpert MTB/RIF and Xpert MTB/RIF Ultra (Xpert Ultra) are World Health
Organization (WHO)‐recommended rapid tests that simultaneously detect tuberculosis and …

[HTML][HTML] Evaluating the diagnostic accuracy of Xpert MTB/RIF assay in pulmonary tuberculosis

SK Sharma, M Kohli, RN Yadav, J Chaubey, D Bhasin… - PloS one, 2015 - journals.plos.org
Pulmonary tuberculosis still remains a major communicable disease worldwide. In 2013, 9
million people developed TB and 1.5 million people died from the disease. India constitutes …

[HTML][HTML] South African guideline for the management of community-acquired pneumonia in adults

TH Boyles, A Brink, GL Calligaro, C Cohen… - Journal of Thoracic …, 2017 - ncbi.nlm.nih.gov
Executive summary Improving the care of patients with community-acquired pneumonia
(CAP) in South Africa is particularly important because of the high burden of disease and the …

Xpert MTB/RIF―why the lack of morbidity and mortality impact in intervention trials?

AF Auld, KL Fielding, A Gupta-Wright… - Transactions of the …, 2016 - academic.oup.com
Compared with smear microscopy, the Xpert MTB/RIF assay (Xpert), with superior accuracy
and capacity to diagnose rifampicin resistance, has advanced TB diagnostic capability …

[图书][B] WHO consolidated guidelines on tuberculosis: module 3: diagnosis–rapid diagnostics for tuberculosis detection: web annex 4: evidence synthesis and analysis

World Health Organization - 2020 - apps.who.int
Under the terms of this licence, you may copy, redistribute and adapt the work for non-
commercial purposes, provided the work is appropriately cited, as indicated below. In any …

Severe tuberculosis requiring intensive care: a descriptive analysis

RP Duro, P Figueiredo Dias, AA Ferreira… - … care research and …, 2017 - Wiley Online Library
Background. This study aims to describe the characteristics of tuberculosis (TB) patients
requiring intensive care and to determine the in‐hospital mortality and the associated …

[HTML][HTML] Management of drug-resistant tuberculosis in special sub-populations including those with HIV co-infection, pregnancy, diabetes, organ-specific dysfunction …

A Esmail, NF Sabur, I Okpechi… - Journal of thoracic …, 2018 - ncbi.nlm.nih.gov
Tuberculosis remains a major problem globally, and is the leading cause of death from an
infectious agent. Drug-resistant tuberculosis threatens to marginalise the substantial gains …

Treatment outcomes, diagnostic and therapeutic impact: Xpert vs. smear. A systematic review and meta-analysis

T Agizew, R Boyd, AF Auld, L Payton… - … of Tuberculosis and …, 2019 - ingentaconnect.com
BACKGROUND: Compared with smear microscopy, Xpert® MTB/RIF has the potential to
reduce delays in tuberculosis (TB) diagnosis and treatment initiation, and improve treatment …

[HTML][HTML] Interventions to reduce deaths in people living with HIV admitted to hospital in low-and middle-income countries: a systematic review

RM Burke, HH Twabi, C Johnston… - PLOS Global Public …, 2023 - journals.plos.org
People living with HIV (PLHIV) admitted to hospital have a high risk of death. We
systematically appraised evidence for interventions to reduce mortality among hospitalised …